SCHEMBL14083719

SCHEMBL14083719

CCOc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(F)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.56
▸ RAB9A P51151 5/20 0.56
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ GAA P10253 2/20 0.54
▸ KDM4E B2RXH2 3/20 0.53
▸ MITF O75030 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ LMNA P02545 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ USP2 O75604 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KCNQ3 O43525 1/20 0.50
▸ KCNQ2 O43526 1/20 0.50
▸ TAS1R3 Q7RTX0 1/20 0.50
▸ TAS1R1 Q7RTX1 1/20 0.50
▸ TRPV1 Q8NER1 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083711 0.92 MAPT (0.54) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL14083718 0.90 KMT2A (0.52) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL14083634 0.90 RAB9A (0.53) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL14083700 0.89 TP53 (0.55) NPC1RAB9ASMN1; SMN2MAPTGAA
SCHEMBL14083840 0.88 NPC1 (0.56) NPC1RAB9ASMN1; SMN2MAPTGAA
SCHEMBL14083699 0.87 RAB9A (0.55) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL14083706 0.86 TRPV1 (0.54) KMT2AMEN1KCNQ3KCNQ2TRPV1
SCHEMBL14083635 0.86 TRPV1 (0.56) KMT2AUSP2MEN1KCNQ3KCNQ2
SCHEMBL14083707 0.86 TRPV1 (0.56) KMT2AMEN1KCNQ3KCNQ2TRPV1
SCHEMBL14083673 0.86 LMNA (0.53) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 NPC1 1061/4885RAB9A 1914/4885SMN1; SMN2 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback